Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era.

Porrett PM, Peterman H, Rosen M, Sonnad S, Soulen M, Markmann JF, Shaked A, Furth E, Reddy KR, Olthoff K.

Liver Transpl. 2006 Apr;12(4):665-73.

2.

Impact of model for end-stage liver disease on patient survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma.

Moonka D, Castillo E, Kumer S, Abouljoud M, Divine G, Pelletier S.

Transplant Proc. 2009 Jan-Feb;41(1):216-8. doi: 10.1016/j.transproceed.2008.09.060.

PMID:
19249517
3.

Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.

Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H; Kagoshima Liver Cancer Study Group.

J Hepatobiliary Pancreat Surg. 2009;16(3):359-66. doi: 10.1007/s00534-009-0069-7. Epub 2009 Mar 20.

PMID:
19300896
4.

Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival.

Bharat A, Brown DB, Crippin JS, Gould JE, Lowell JA, Shenoy S, Desai NM, Chapman WC.

J Am Coll Surg. 2006 Oct;203(4):411-20. Epub 2006 Aug 17.

PMID:
17000383
5.

[Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].

Díaz-Sánchez A, Matilla A, Núñez O, Merino B, Peligros I, Rincón D, Salcedo M, Lo Iacono O, Vega Catalina M, Clemente G, Bañares R.

Gastroenterol Hepatol. 2010 Mar;33(3):155-64. doi: 10.1016/j.gastrohep.2009.10.001. Epub 2009 Nov 30. Spanish.

PMID:
19945770
6.

Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.

Lao OB, Weissman J, Perkins JD.

Clin Transplant. 2009 Nov-Dec;23(6):874-81. doi: 10.1111/j.1399-0012.2009.00993.x. Epub 2009 May 4.

PMID:
19453644
8.

Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.

Ruzzenente A, Capra F, Pachera S, Iacono C, Piccirillo G, Lunardi M, Pistoso S, Valdegamberi A, D'Onofrio M, Guglielmi A.

J Gastrointest Surg. 2009 Jul;13(7):1313-20. doi: 10.1007/s11605-009-0903-x. Epub 2009 May 6.

PMID:
19418103
9.

Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.

Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, Margreiter R, Vogel W.

Liver Transpl. 2003 Jun;9(6):557-63.

10.

Liver transplantation for hepatocellular carcinoma: the MELD impact.

Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH.

Liver Transpl. 2004 Jan;10(1):36-41.

11.

Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.

Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S.

Surgery. 2007 Mar;141(3):330-9. Epub 2006 Nov 1.

PMID:
17349844
12.

Liver transplant for hepatocellular carcinoma: experience in a Saudi population.

Allam N, Khalaf H, Fagih M, Al-Sebayel M.

Exp Clin Transplant. 2008 Mar;6(1):14-24.

13.

Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma.

Sandroussi C, Dawson LA, Lee M, Guindi M, Fischer S, Ghanekar A, Cattral MS, McGilvray ID, Levy GA, Renner E, Greig PD, Grant DR.

Transpl Int. 2010 Mar 1;23(3):299-306. doi: 10.1111/j.1432-2277.2009.00980.x. Epub 2009 Oct 15.

14.

Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.

Wong SN, Reddy KR, Keeffe EB, Han SH, Gaglio PJ, Perrillo RP, Tran TT, Pruett TL, Lok AS.

Liver Transpl. 2007 Mar;13(3):334-42.

15.

Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.

Okuwaki Y, Nakazawa T, Kokubu S, Hidaka H, Tanaka Y, Takada J, Watanabe M, Shibuya A, Minamino T, Saigenji K.

Am J Gastroenterol. 2009 Nov;104(11):2747-53. doi: 10.1038/ajg.2009.414. Epub 2009 Jul 14.

PMID:
19603009
16.

Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies.

El-Gazzaz G, Sourianarayanane A, Menon KV, Sanabria J, Hashimoto K, Quintini C, Kelly D, Eghtesad B, Miller C, Fung J, Aucejo F.

Hepatobiliary Pancreat Dis Int. 2013 Feb;12(1):34-41.

PMID:
23392796
17.

Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy.

Huo TI, Huang YH, Su CW, Lin HC, Chiang JH, Chiou YY, Huo SC, Lee PC, Lee SD.

Clin Transplant. 2008 Jul-Aug;22(4):469-75. doi: 10.1111/j.1399-0012.2008.00811.x. Epub 2008 Mar 3.

PMID:
18318736
18.

Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.

Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, Durazo F, Saab S, Han S, Finn R, Hiatt JR, Busuttil RW.

Hepatology. 2005 May;41(5):1130-7.

PMID:
15841454
19.
20.

Hepatocellular carcinoma: interventional bridging to liver transplantation.

Lubienski A.

Transplantation. 2005 Sep 27;80(1 Suppl):S113-9. Review.

PMID:
16286887

Supplemental Content

Support Center